Lingtong Zhi

1.4k total citations
31 papers, 956 citations indexed

About

Lingtong Zhi is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Lingtong Zhi has authored 31 papers receiving a total of 956 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 12 papers in Oncology and 10 papers in Molecular Biology. Recurrent topics in Lingtong Zhi's work include Immune Cell Function and Interaction (11 papers), CAR-T cell therapy research (10 papers) and Genetics, Aging, and Longevity in Model Organisms (6 papers). Lingtong Zhi is often cited by papers focused on Immune Cell Function and Interaction (11 papers), CAR-T cell therapy research (10 papers) and Genetics, Aging, and Longevity in Model Organisms (6 papers). Lingtong Zhi collaborates with scholars based in China, United States and United Kingdom. Lingtong Zhi's co-authors include Dayong Wang, Carla M. Suto, R A Heyman, E. Berger, Marcus F. Boehm, Dale E. Mais, Michael McClurg, Yonglin Yu, Wuling Zhu and Julia A. Davies and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and Scientific Reports.

In The Last Decade

Lingtong Zhi

28 papers receiving 943 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lingtong Zhi China 16 424 249 240 174 145 31 956
Zhijie Liu United States 18 878 2.1× 138 0.6× 50 0.2× 108 0.6× 28 0.2× 46 1.4k
Casilda V. Mura United States 19 513 1.2× 81 0.3× 145 0.6× 18 0.1× 37 0.3× 35 1.1k
Rafał Kozieł Austria 17 517 1.2× 60 0.2× 214 0.9× 23 0.1× 123 0.8× 21 1.0k
Ting Huyan China 17 416 1.0× 89 0.4× 191 0.8× 59 0.3× 10 0.1× 41 867
Aditi U. Gurkar United States 15 616 1.5× 119 0.5× 125 0.5× 15 0.1× 148 1.0× 27 1.1k
Lu Qiu China 18 537 1.3× 98 0.4× 180 0.8× 14 0.1× 21 0.1× 51 876
Eun‐Soo Kwon South Korea 20 534 1.3× 90 0.4× 126 0.5× 19 0.1× 275 1.9× 29 1.1k
Sang‐Hyun Min South Korea 18 608 1.4× 148 0.6× 125 0.5× 40 0.2× 7 0.0× 48 880
Yingzi Li China 16 354 0.8× 74 0.3× 50 0.2× 36 0.2× 26 0.2× 67 735

Countries citing papers authored by Lingtong Zhi

Since Specialization
Citations

This map shows the geographic impact of Lingtong Zhi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingtong Zhi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingtong Zhi more than expected).

Fields of papers citing papers by Lingtong Zhi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lingtong Zhi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingtong Zhi. The network helps show where Lingtong Zhi may publish in the future.

Co-authorship network of co-authors of Lingtong Zhi

This figure shows the co-authorship network connecting the top 25 collaborators of Lingtong Zhi. A scholar is included among the top collaborators of Lingtong Zhi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lingtong Zhi. Lingtong Zhi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhi, Lingtong, Zikang Zhang, Qing Gao, et al.. (2025). CAR-NK cells with dual targeting of PD-L1 and MICA/B in lung cancer tumor models. BMC Cancer. 25(1). 337–337. 5 indexed citations
2.
Sun, Yang, et al.. (2025). A membrane-bound IL-2 promotes CAR-NK cell proliferation, anti-apoptosis and anti-tumor activity. Biochemical and Biophysical Research Communications. 781. 152495–152495.
3.
Niu, Zhiyuan, Mengjun Wang, Bingqian Xu, et al.. (2024). Challenges in the Development of NK-92 Cells as an Effective Universal Off-the-Shelf Cellular Therapeutic. The Journal of Immunology. 213(9). 1318–1328.
4.
Meng, Dong, Xiang Wang, Lingtong Zhi, et al.. (2024). A novel MICA/B-targeted chimeric antigen receptor augments the cytotoxicity of NK cells against tumor cells. Biochemical and Biophysical Research Communications. 710. 149918–149918. 5 indexed citations
5.
Guo, Changjiang, Han Chen, Jie Yu, et al.. (2023). Engagement of an optimized lentiviral vector enhances the expression and cytotoxicity of CAR in human NK cells. Molecular Immunology. 155. 91–99. 7 indexed citations
6.
Zhi, Lingtong, Meichen Yin, Xin Su, et al.. (2022). A chimeric switch-receptor PD1-DAP10-41BB augments NK92-cell activation and killing for human lung Cancer H1299 Cell. Biochemical and Biophysical Research Communications. 600. 94–100. 3 indexed citations
7.
Zhi, Lingtong, Xin Su, Meichen Yin, et al.. (2021). Genetical engineering for NK and T cell immunotherapy with CRISPR/Cas9 technology: Implications and challenges. Cellular Immunology. 369. 104436–104436. 8 indexed citations
8.
Niu, Zhiyuan, et al.. (2020). Explore the activation efficiency of different ligand carriers on synNotch-based contact-dependent activation system. Turkish Journal of Biochemistry. 45(6). 817–823. 2 indexed citations
9.
Guo, Changjiang, Han Chen, Huiyong Zhang, et al.. (2020). A novel chimeric PD1-NKG2D-41BB receptor enhances antitumor activity of NK92 cells against human lung cancer H1299 cells by triggering pyroptosis. Molecular Immunology. 122. 200–206. 85 indexed citations
10.
Niu, Zhiyuan, Wei Chun Chang, Huiyong Zhang, et al.. (2020). Chimeric antigen receptor‐modified macrophages trigger systemic anti‐tumour immunity. The Journal of Pathology. 253(3). 247–257. 85 indexed citations
11.
Zhang, Huiyong, Liang Chen, Xiaoyin Wang, et al.. (2020). VEGF165b and its mutant demonstrate immunomodulatory, not merely anti-angiogenic functions, in tumor-bearing mice. Molecular Immunology. 122. 132–140. 4 indexed citations
12.
Guo, Changjiang, Xiaoyin Wang, Huiyong Zhang, et al.. (2019). Structure-based rational design of a novel chimeric PD1-NKG2D receptor for natural killer cells. Molecular Immunology. 114. 108–113. 36 indexed citations
13.
Zhi, Lingtong, et al.. (2017). Molecular Control of Innate Immune Response to Pseudomonas aeruginosa Infection by Intestinal let-7 in Caenorhabditis elegans. PLoS Pathogens. 13(1). e1006152–e1006152. 32 indexed citations
14.
Zhi, Lingtong, Yonglin Yu, Zhixia Jiang, & Dayong Wang. (2017). mir-355 Functions as An Important Link between p38 MAPK Signaling and Insulin Signaling in the Regulation of Innate Immunity. Scientific Reports. 7(1). 14560–14560. 16 indexed citations
15.
Zhi, Lingtong, et al.. (2016). Wnt Ligands Differentially Regulate Toxicity and Translocation of Graphene Oxide through Different Mechanisms in Caenorhabditis elegans. Scientific Reports. 6(1). 39261–39261. 26 indexed citations
16.
Wu, Qiuli, et al.. (2016). Quantum dots increased fat storage in intestine of Caenorhabditis elegans by influencing molecular basis for fatty acid metabolism. Nanomedicine Nanotechnology Biology and Medicine. 12(5). 1175–1184. 36 indexed citations
17.
Sun, Lingmei, et al.. (2016). microRNAs Involved in the Control of Innate Immunity in Candida Infected Caenorhabditis elegans. Scientific Reports. 6(1). 36036–36036. 24 indexed citations
18.
Yu, Yonglin, et al.. (2016). NPR-9 regulates the innate immune response in Caenorhabditis elegans by antagonizing the activity of AIB interneurons. Cellular and Molecular Immunology. 15(1). 27–37. 35 indexed citations
19.
Zhi, Lingtong, Li Dong, Binbin Sun, et al.. (2013). Curcumin acts via transient receptor potential vanilloid‐1 receptors to inhibit gut nociception and reverses visceral hyperalgesia. Neurogastroenterology & Motility. 25(6). e429–40. 39 indexed citations
20.
Boehm, Marcus F., Lutao Zhang, Lingtong Zhi, et al.. (1995). Design and Synthesis of Potent Retinoid X Receptor Selective Ligands That Induce Apoptosis in Leukemia Cells. Journal of Medicinal Chemistry. 38(16). 3146–3155. 283 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhijie Liu Breakdown of academic impact, for papers by Casilda V. Mura Breakdown of academic impact, for papers by Rafał Kozieł Breakdown of academic impact, for papers by Ting Huyan Breakdown of academic impact, for papers by Aditi U. Gurkar Breakdown of academic impact, for papers by Lu Qiu Breakdown of academic impact, for papers by Eun‐Soo Kwon Breakdown of academic impact, for papers by Sang‐Hyun Min Breakdown of academic impact, for papers by Yingzi Li
Rankless by CCL
2026